Télécharger le supplément (250 p.) - KCE

KCE Reports 85 S Médecine à l’acte/médecine au forfait – ANNEXES 7
29. The percentage of patients with
coronary heart disease who have a
record of influenza vaccination in the
preceeding 1 September to 31 march
36 OUI Voir vaccinations.
Tableau 2: Indicateurs spécifiques aux antécédents d’infarctus.
Indicator Réf Mesurable
a priori
1. Record that low-dose ASA and
beta-blockers, if not contraindicated,
are prescribed routinely to myocardial
infarction survivors regardless of age or
sex
2. Rates of prescribing of betablockers
for patients admitted to
hospital for AMI or angina
( prior to the study): 6 months after
discharge
(target standard: implicit 100%)
3. Prescribing of beta-blockers:
target standards: 100% of patients with
recent AMI and no contraindication
4. Drug therapy: beta-blockers:
target standards : implicit 100% when
patients < 2 years post AMI with no
contraindications
5. Patients with a history of acute
MI should be currently prescribed a
beta-blocking drug indefinitely, unless
specific contraindications exist
6. Risk factor recording in previous
year for post-MI patients : cholesterol
1,2,3,7,8 Aspirine:
non
Beta-bloq:
oui
Measure to ask Comment
Beta-blockers
prescription for
patiens with
antecedent of
infarction:
- Among patients
with antecedent of
infarction, number of
patients treated with
beta-blockers
- Dates of
prescriptions of betablockers
- (+ dates of
thrombolysis or of
stenting)
8 OUI Measure of
cholesterol for
patients with
antecedent of
infarction:
- Number of times
that cholesterol has
been measured for
patients with
antecedent of
infarction
- Number of patients
with antecedent of
infarction for which
cholesterol has been
measured
- Time between the
measures of
cholesterol
? 6 mois après la sortie de
l’hôpital
? recent
délai